How have BBH shares performed in 2023?

VanEck Biotech ETF's stock was trading at $159.74 at the beginning of 2023. Since then, BBH stock has decreased by 3.6% and is now trading at $153.96. View the best growth stocks for 2023 here .

Are investors shorting VanEck Biotech ETF?

VanEck Biotech ETF saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 7,600 shares, an increase of 7.0% from the October 31st total of 7,100 shares. Based on an average daily trading volume, of 7,700 shares, the short-interest ratio is presently 1.0 days. View VanEck Biotech ETF's Short Interest .

How often does VanEck Biotech ETF pay dividends? What is the dividend yield for VanEck Biotech ETF?

VanEck Biotech ETF announced an annual dividend on Friday, December 16th. Stockholders of record on Tuesday, December 20th will be paid a dividend of $0.749 per share on Friday, December 23rd. This represents a dividend yield of 0.47%. The ex-dividend date is Monday, December 19th. This is a boost from the stock's previous annual dividend of $0.40. Read our dividend analysis for BBH .

What does BBH invest in?

VanEck Biotech ETF is a equity fund issued by Van Eck. BBH focuses on health care investments and follows the Market Vectors US Listed Biotech 25 Index. The fund's investments total to approximately $456.88 million assets under management.

What stocks does VanEck Biotech ETF hold?

BBH invests in 25 holdings. Some of the stocks in their portfolio include Amgen (AMGN) , Gilead Sciences (GILD) , Vertex Pharmaceuticals (VRTX) , Regeneron Pharmaceuticals (REGN) , argenx (ARGX) , IQVIA (IQV) , Seagen (SGEN) , ICON Public (ICLR) , Biogen (BIIB) and Moderna (MRNA) .

What is the management fee for VanEck Biotech ETF?

VanEck Biotech ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for BBH is 0.35%.

What other stocks do shareholders of VanEck Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Biotech ETF investors own include Gilead Sciences (GILD) , Inovio Pharmaceuticals (INO) , Pfizer (PFE) , Intel (INTC) , Micron Technology (MU) , Cidara Therapeutics (CDTX) , Quest Diagnostics (DGX) , Novavax (NVAX) .

Who are VanEck Biotech ETF's major shareholders?

VanEck Biotech ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Miller Investment Management LP (6.12%), JPMorgan Chase & Co. (2.07%), LPL Financial LLC (1.49%), Commonwealth Equity Services LLC (0.99%), UBS Group AG (0.94%) and Royal Bank of Canada (0.86%).

How do I buy shares of VanEck Biotech ETF?

Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

VanEck Biotech ETF (BBH) Price, Holdings, & News

$153.96

-1.28 (-0.82%)

(As of 12/8/2023 ET)

Compare

Today's Range: $153.91
▼
$155.17
50-Day Range: $143.93
▼
$159.18
52-Week Range: $142.51
▼
$170.25

Volume: 9,761 shs
Average Volume: 11,690 shs
Market Capitalization: $449.56 million

Assets Under Management: $456.88 million
Dividend Yield: 0.49%
Net Expense Ratio: 0.35%

About VanEck Biotech ETF (NASDAQ:BBH)

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

BBH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BBH ETF News Headlines

October 24, 2023 | investing.com

BBH ETF Stock Price History

September 13, 2023 | msn.com

BBH: Our Favorite Biotech ETF Can Keep Outperforming

December 9, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

August 7, 2023 | morningstar.com

VanEck ETFs

May 27, 2023 | msn.com

BBH: A Solid Choice For Biotech Exposure

May 13, 2023 | marketwatch.com

Van Eck Biotech Etf $BBH Trading Report

May 3, 2023 | marketwatch.com

When the Price of Van Eck Biotech Etf $BBH Talks, People Listen

April 25, 2023 | seekingalpha.com

BBH VanEck Biotech ETF

December 9, 2023 | DTI Trader (Ad)

All the trading advice you’ve ever received boils down to this

All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.

April 24, 2023 | marketwatch.com

Van Eck Biotech Etf $BBH Pivots Trading Plans and Risk Controls

See More Headlines

Receive BBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: Van Eck
Fund Name: VanEck Biotech ETF
Tax Classification: Regulated Investment Company
Stock Exchange: NASDAQ
Current Symbol: NASDAQ:BBH
Inception Date: 12/20/2011
Fund Manager: Hao-Hung Peter Liao, Guo Hua Jason Jin
Web: N/A
Phone: N/A

Fund Focus

Asset Class: Equity
Benchmark: Market Vectors US Listed Biotech 25 Index
Category: Sector
Focus: Health Care
Development Level: Developed Markets
Region: Global
Number of Holdings: 25

Fund Statistics

Assets Under Management: $456.88 million
Average Daily Volume: $12,086.70
Discount/Premium: 0.18%

Administrator, Advisor and Custodian

Administrator: Van Eck Associates Corporation
Advisor: Van Eck Associates Corporation
Custodian: State Street Bank and Trust Company
Distributor: Van Eck Securities Corporation
Transfer Agent: State Street Bank and Trust Company
Trustee: N/A
Lead Market Maker: Virtu Financial

Options

Optionable: Optionable
Options Volume: 9
Put Options: 1
Call Options: 8
Short Interest: 7,600 shs

Miscellaneous

Outstanding Shares: 2,900,000
Beta: 0.79
Creation Unit: 50,000
Creation Fee: $500.00

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

VanEck Biotech ETF Expenses

Type	BBH	Health Care ETFs	Equity ETFs	NASDAQ ETFs	All ETFs
Management Fee	0.35%	0.56%	0.53%	0.47%	0.51%
Other Expenses	0.00%	0.40%	0.54%	0.29%	0.57%
Total Expense	0.35%	0.72%	0.70%	0.56%	0.70%
Fee Waiver	0.00%	-0.51%	-0.54%	-0.21%	-0.58%
Net Expense	0.35%	0.61%	0.60%	0.52%	0.57%

VanEck Biotech ETF (BBH) Holdings & Exposure

Top 10 BBH Holdings

BBH Sector Exposure

BBH Industry Exposure

Full Holdings Details

Similar ETFs

Institutional Ownership

View All Institutional Transactions

BBH ETF - Frequently Asked Questions

How have BBH shares performed in 2023?: VanEck Biotech ETF's stock was trading at $159.74 at the beginning of 2023. Since then, BBH stock has decreased by 3.6% and is now trading at $153.96.
View the best growth stocks for 2023 here.
Are investors shorting VanEck Biotech ETF?: VanEck Biotech ETF saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 7,600 shares, an increase of 7.0% from the October 31st total of 7,100 shares. Based on an average daily trading volume, of 7,700 shares, the short-interest ratio is presently 1.0 days.
View VanEck Biotech ETF's Short Interest.
How often does VanEck Biotech ETF pay dividends? What is the dividend yield for VanEck Biotech ETF?: VanEck Biotech ETF announced an annual dividend on Friday, December 16th. Stockholders of record on Tuesday, December 20th will be paid a dividend of $0.749 per share on Friday, December 23rd. This represents a dividend yield of 0.47%. The ex-dividend date is Monday, December 19th. This is a boost from the stock's previous annual dividend of $0.40.
Read our dividend analysis for BBH.
What does BBH invest in?: VanEck Biotech ETF is a equity fund issued by Van Eck. BBH focuses on health care investments and follows the Market Vectors US Listed Biotech 25 Index. The fund's investments total to approximately $456.88 million assets under management.
What stocks does VanEck Biotech ETF hold?: BBH invests in 25 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), argenx (ARGX), IQVIA (IQV), Seagen (SGEN), ICON Public (ICLR), Biogen (BIIB) and Moderna (MRNA).

What is the management fee for VanEck Biotech ETF?: VanEck Biotech ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for BBH is 0.35%.
What other stocks do shareholders of VanEck Biotech ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Intel (INTC), Micron Technology (MU), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Novavax (NVAX).
Who are VanEck Biotech ETF's major shareholders?: VanEck Biotech ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Miller Investment Management LP (6.12%), JPMorgan Chase & Co. (2.07%), LPL Financial LLC (1.49%), Commonwealth Equity Services LLC (0.99%), UBS Group AG (0.94%) and Royal Bank of Canada (0.86%).
How do I buy shares of VanEck Biotech ETF?: Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:BBH) was last updated on 12/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial